Biotech · Private company
Daré Bioscience, Inc.
Track this companyFree. Adds Daré Bioscience, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- DARE-BV1clindamycin phosphate vaginal gel, 2%Phase 3 · Bacterial VaginosisClinicalTrials.gov · fetched Nov 12, 2026
- Lopinavir / ritonavirPhase 2 · Human Papilloma Virus (HPV)ClinicalTrials.gov · fetched Nov 12, 2026
- DARE-BV1Phase 1 · Bacterial VaginosisClinicalTrials.gov · fetched Nov 12, 2026
- OvapreneContraceptionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)PHASE2 · RECRUITING · started Jul 17, 2026ClinicalTrials.gov NCT07601074 · fetched Nov 12, 2026
- Contraceptive Efficacy Study of OvapreneNA · RECRUITING · started Dec 19, 2023ClinicalTrials.gov NCT06127199 · fetched Nov 12, 2026
- Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal DisorderPHASE2 · UNKNOWN · started Jun 28, 2021ClinicalTrials.gov NCT04948151 · fetched Nov 12, 2026
- Pharmacokinetic Study of DARE-BV1PHASE1 · COMPLETED · started Nov 3, 2020ClinicalTrials.gov NCT05354050 · fetched Nov 12, 2026
- DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)PHASE3 · COMPLETED · started Jun 16, 2020ClinicalTrials.gov NCT04370548 · fetched Nov 12, 2026
- Safety and Acceptability Study of a Non-Hormonal RingNA · COMPLETED · started May 23, 2018ClinicalTrials.gov NCT03598088 · fetched Nov 12, 2026